Addex Therapeutics is a clinical-stage pharmaceutical company focused on the development and commercialization of an emerging class of novel orally available small molecule drugs known as allosteric modulators for neurological disorders.

Products, services, technology
  • ADX71149 (mGlu2 PAM)
  • Dipraglurant (mGlu5 NAM)
  • GABAB PAM - SUD
  • GABAB PAM - Chronic cough, pain & CMT1A
  • mGlu7 NAM - Stress-related disorders – PTSD
  • mGlu2 NAM - Mild neurocognitive disorders & depression
  • M4 PAM - Schizophrenia
  • mGlu4 PAM - Parkinson’s
  • mGlu3 PAM - Neurodegenerative disorders
Location

Chemin des Mines 9, 1202 Geneva, Switzerland

Facts & figures
  • Type of organization
    Public company
  • Year of foundation
    2002
  • Number of employees in Switzerland
    20-49
Key business